Schizophrenia develops through a combination of genetic vulnerability, brain chemistry changes, and environmental triggers, not any single cause. It affects about 1 in 345 people worldwide, and most cases emerge in late adolescence or early adulthood. Understanding how all these factors interact helps explain why some people develop the condition while others with similar risk factors never do.
Genetics Set the Foundation
Genes are the single largest risk factor. A landmark study using the Danish Twin Register estimated schizophrenia’s heritability at 79%, meaning that roughly four-fifths of the variation in who develops it can be traced to genetic differences. Among identical twins who share all their DNA, if one twin has schizophrenia, the other has a 33% chance of developing it too. For fraternal twins, who share about half their DNA, that drops to 7%.
That 33% concordance rate in identical twins is revealing in two directions. It confirms a powerful genetic component, but it also proves genes alone aren’t enough. Two-thirds of identical twins don’t share the diagnosis. Something beyond DNA has to push a genetically vulnerable person toward the condition.
No single “schizophrenia gene” exists. Hundreds of small genetic variations each contribute a tiny amount of risk. Some affect how brain cells communicate, how connections between neurons are pruned during adolescence, or how the brain responds to stress and inflammation.
What Changes in the Brain
Two major chemical signaling systems in the brain appear disrupted in schizophrenia. The older explanation focuses on dopamine: certain brain pathways release too much of it, driving hallucinations and delusions, while other pathways release too little, contributing to emotional flatness and lack of motivation.
A newer and increasingly supported explanation centers on glutamate, the brain’s primary excitatory chemical messenger. In schizophrenia, specific receptors on inhibitory brain cells don’t function properly. These inhibitory cells normally act as brakes, keeping excitatory neurons in check. When the brakes fail, excitatory neurons fire excessively, flooding key brain regions (particularly the prefrontal cortex and hippocampus) with glutamate. Brain imaging studies have confirmed these elevated glutamate levels in people with schizophrenia.
Over time, this excess signaling causes real structural damage. High glutamate levels lead to overactive metabolism in affected areas, structural disorganization, and eventually shrinkage of brain tissue. MRI studies show that measurable changes in brain volume likely occur between the initial high-risk state and the first full psychotic episode. Ongoing reductions in brain volume after onset are associated with worse outcomes. Post-mortem studies point to smaller neurons and reduced branching of the cellular connections between them.
Prenatal and Early Life Triggers
The process of developing schizophrenia can begin before birth. When a pregnant person’s immune system activates strongly, whether from infection, severe stress, or nutritional deficiency, the inflammatory response can alter fetal brain development in ways that increase vulnerability decades later.
Maternal infections linked to higher schizophrenia risk in offspring include influenza, rubella, herpes simplex virus, respiratory infections, and the parasite Toxoplasma gondii. The critical factor doesn’t seem to be any specific pathogen but rather the intensity of the mother’s immune response. Pregnancy and birth complications, intrauterine growth restriction, and nutritional deficiencies during pregnancy also contribute.
These prenatal exposures don’t cause schizophrenia on their own. They appear to create subtle changes in how the developing brain is wired, changes that may remain silent until adolescence or early adulthood, when major brain remodeling occurs.
Cannabis and Substance Use
Cannabis use, particularly during adolescence when the brain is still developing, is one of the most well-documented environmental risk factors. Regular use of high-potency cannabis products increases the risk of developing schizophrenia by roughly four times. In Yale’s early psychosis treatment program, over 75% of patients with early schizophrenia had a history of cannabis use.
Perhaps the most striking finding comes from a Finnish study of 18,000 people who experienced cannabis-induced psychosis (a temporary break from reality triggered by the drug). Nearly half of them were later diagnosed with schizophrenia. This doesn’t mean cannabis directly causes schizophrenia in everyone who uses it, but for people who already carry genetic vulnerability, it can be the environmental push that triggers onset.
Urban Living and Social Stress
Growing up in a city raises the risk of psychosis by about 64% compared to rural areas, and the effect scales with city size. A large Danish study confirmed this isn’t just because people predisposed to psychosis move to cities: moving from a rural area to an urban one increased risk, and moving in the opposite direction lowered it.
Why cities carry extra risk isn’t fully settled. One influential theory, the “social defeat” hypothesis, proposes that experiences of social subordination and exclusion are the common thread linking several risk factors, including immigration, minority status, childhood adversity, and urban living. The idea is that chronic experiences of being on the outside, of not belonging to the dominant group, produce sustained stress that interacts with genetic vulnerability to alter dopamine signaling. Immigrants and their children, for example, consistently show elevated rates of schizophrenia, particularly when they move to areas where their ethnic group is a small minority.
When and How It Typically Appears
Schizophrenia rarely arrives without warning. Before full psychosis, most people go through a prodromal phase lasting an average of about 22 months, though it ranges widely from less than a year to over five years. During this period, changes are real but subtle: difficulty with thinking clearly, problems with memory, unusual perceptual experiences that aren’t quite hallucinations, social withdrawal, declining performance at school or work, and a general sense that something is “off.” These symptoms aren’t severe enough to qualify as psychosis, but they represent a measurable decline from the person’s previous functioning.
Onset tends to follow a rough “rule of thirds.” Among people in this high-risk prodromal state who go on to develop full psychosis, about one-third convert within the first year, another third between one and two years, and the final third after more than two years.
Men typically develop schizophrenia one to four years earlier than women, with male onset peaking in the late teens to early twenties and female onset peaking in the mid-to-late twenties. Men also tend to have a more severe course, with greater developmental difficulties before onset and worse overall adjustment. Women more often have a later, milder course with better functioning before and after diagnosis. Estrogen is thought to play a protective role, which may explain why some women experience a second peak of risk after menopause when estrogen levels drop.
How These Factors Work Together
Schizophrenia is best understood as the endpoint of multiple hits accumulating over a lifetime. A person might inherit a set of risk genes, experience prenatal immune activation that subtly alters brain wiring, grow up in a stressful urban environment, and begin using cannabis in adolescence. Each factor alone might not be enough. Together, they push the brain past a threshold where its signaling systems can no longer compensate, and psychosis emerges.
This “multiple hit” model explains why the condition runs in families without following a simple inheritance pattern, why identical twins often don’t share the diagnosis, and why some people with heavy cannabis use or difficult childhoods never develop psychosis while others with seemingly fewer risk factors do. The specific combination of vulnerabilities and exposures matters more than any single cause.